Revreboot,
the first obvious positive is direction of Fonda revenues to ACL holders rather than to Oncology development.
The corresponding down side is dilution in our holding in the new oncology spin off.
the second positive is potential revenues from HyAct at half a billion pa
the third positive is a buy in price that is seemingly a bargain. Those that got in at .25c this morning are laughing I'm sure.
There was always going to be dilution so we should all just move on a get set.
Cheers
Mulac
good on any construction??, page-8
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable